Analyst Consensus ?
ConsensusBuy36 ratings
Bullish2466.7%
Neutral1027.8%
Bearish25.5%
FN2 Earnings Intelligence
Corteva, Inc. analyst ratings
Corteva, Inc. (CTVA) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$11.63Current
$15Low
$62.4Average
$101High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 12, 2026 |
| Keybanc | Overweight | Sector Weight | Upgrade | Oct 7, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Oct 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Sep 18, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Sep 17, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 16, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 16, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 23, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 11, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | May 28, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 21, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 6, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 12, 2024 |
| OTR Global | Negative | Mixed | Downgrade | Jun 7, 2024 |
| Canaccord Genuity | Buy | Buy | Maintain | May 3, 2024 |
| Loop Capital | Buy | Hold | Upgrade | Feb 12, 2024 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Feb 2, 2024 |
| Roth MKM | Buy | Buy | Maintain | Jan 29, 2024 |
| Berenberg | Hold | Buy | Downgrade | Nov 27, 2023 |
| Fermium Research | Outperform | Outperform | Maintain | Oct 30, 2023 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 24, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 4, 2023 |
| Redburn Partners | Neutral | Buy | Downgrade | Jul 25, 2023 |
| Vertical Research | Buy | Hold | Upgrade | May 22, 2023 |
| Roth Capital | Buy | Buy | Maintain | Oct 8, 2021 |
| Monness, Crespi, Hardt | Neutral | Sell | Upgrade | Aug 9, 2021 |
| Redburn | Neutral | Buy | Downgrade | Jan 21, 2021 |
| Susquehanna | Positive | Neutral | Upgrade | Mar 31, 2020 |
| Edward Jones | Buy | Hold | Upgrade | Mar 19, 2020 |
| Bernstein | Outperform | Market Perform | Upgrade | Jan 23, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Oct 11, 2019 |
| Citi | Buy | Neutral | Upgrade | Aug 19, 2019 |
| Monness Crespi Hardt | Sell | Sell | Maintain | Jul 17, 2019 |
| Nomura | Neutral | Neutral | Maintain | Jun 10, 2019 |
Named analyst price targets
Upside is calculated against the persisted current price $11.63. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $15 | $12.91 | +29.0% | Oct 12, 2026 |
| Goldman Sachs | Duffy Fischer | $20 | $14.45 | +72.0% | Oct 8, 2026 |
| RBC Capital | Arun Viswanathan | $17 | $13.91 | +46.2% | Oct 7, 2026 |
| KeyBanc | Salvator Tiano | $17 | $13.91 | +46.2% | Oct 7, 2026 |
| New Street | Analyst unavailable | $17 | $11.92 | +46.2% | Oct 5, 2026 |
| Oppenheimer | Kristen Owen | $17 | $11.92 | +46.2% | Oct 5, 2026 |
| BMO Capital | Analyst unavailable | $15 | $12.57 | +29.0% | Oct 2, 2026 |
| Morgan Stanley | Analyst unavailable | $18 | $12.57 | +54.8% | Oct 2, 2026 |
| Oppenheimer | Kristen Owen | $95 | $80.45 | +716.9% | Sep 24, 2026 |
| BMO Capital | Joel Jackson | $95 | $83.11 | +716.9% | Sep 16, 2026 |
| New Street | Analyst unavailable | $95 | $83.39 | +716.9% | Sep 16, 2026 |
| UBS | Analyst unavailable | $90 | $83.39 | +673.9% | Sep 16, 2026 |
| Deutsche Bank | David Begleiter | $101 | $77.75 | +768.4% | Aug 3, 2026 |
| BMO Capital | Joel Jackson | $100 | $78.71 | +759.8% | Aug 3, 2026 |
| RBC Capital | Arun Viswanathan | $103 | $86.78 | +785.6% | Jul 21, 2026 |
| Mizuho Securities | Analyst unavailable | $97 | $85.72 | +734.0% | Jul 14, 2026 |
| Mizuho Securities | Analyst unavailable | $96 | $85.25 | +725.5% | Jul 2, 2026 |
| Barclays | Benjamin Theurer | $91 | $74.46 | +682.5% | Jun 11, 2026 |
| UBS | Joshua Spector | $86 | $75.86 | +639.5% | Jun 9, 2026 |
| Morgan Stanley | Vincent Andrews | $95 | $79.89 | +716.9% | May 28, 2026 |
| RBC Capital | Arun Viswanathan | $95 | $78.62 | +716.9% | Apr 24, 2026 |
| Wells Fargo | Analyst unavailable | $90 | $80.29 | +673.9% | Apr 21, 2026 |
| UBS | Analyst unavailable | $88 | $83.56 | +656.7% | Apr 9, 2026 |
| Mizuho Securities | Analyst unavailable | $82 | $75.03 | +605.1% | Feb 17, 2026 |
| UBS | Joshua Spector | $80 | $72.6 | +587.9% | Feb 9, 2026 |
| RBC Capital | Analyst unavailable | $89 | $72.99 | +665.3% | Feb 5, 2026 |
| Oppenheimer | Analyst unavailable | $86 | $72.99 | +639.5% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $88 | $75.12 | +656.7% | Feb 5, 2026 |
| Wells Fargo | Analyst unavailable | $85 | $75.12 | +630.9% | Feb 5, 2026 |
| Oppenheimer | Analyst unavailable | $78 | $72.63 | +570.7% | Jan 27, 2026 |
| Mizuho Securities | Edlain Rodriguez | $80 | $70.5 | +587.9% | Jan 16, 2026 |
| Oppenheimer | Analyst unavailable | $76 | $63.38 | +553.5% | Nov 7, 2025 |
| UBS | Analyst unavailable | $81 | $61.53 | +596.5% | Oct 30, 2025 |
| Oppenheimer | Analyst unavailable | $75 | $62.79 | +544.9% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $80 | $61.91 | +587.9% | Oct 16, 2025 |
| Mizuho Securities | Analyst unavailable | $78 | $65.61 | +570.7% | Oct 8, 2025 |
| UBS | Analyst unavailable | $85 | $64.56 | +630.9% | Oct 6, 2025 |
| Morgan Stanley | Analyst unavailable | $84 | $74.29 | +622.3% | Sep 15, 2025 |
| BMO Capital | Analyst unavailable | $86 | $74.29 | +639.5% | Sep 15, 2025 |
| Oppenheimer | Kristen Owen | $87 | $72.09 | +648.1% | Jul 15, 2025 |
| KeyBanc | Aleksey Yefremov | $71 | $60.29 | +510.5% | Apr 14, 2025 |
| KeyBanc | Aleksey Yefremov | $69 | $60.76 | +493.3% | Nov 21, 2024 |
| Citigroup | Patrick Cunningham | $68 | $59.12 | +484.7% | Oct 23, 2024 |
| Bank of America Securities | Steve Byrne | $67 | $57.3 | +476.1% | Oct 16, 2024 |
| Mizuho Securities | John Roberts | $61 | $57.85 | +424.5% | Sep 25, 2024 |
| Oppenheimer | Kriten Owen | $69 | $57.04 | +493.3% | Sep 17, 2024 |
| KeyBanc | Aleksey Yefremov | $62 | $53 | +433.1% | Aug 2, 2024 |
| Mizuho Securities | John Roberts | $60 | $51.89 | +415.9% | Jun 18, 2024 |
| Wolfe Research | Chris Parkinson | $68 | $51.9 | +484.7% | Jun 11, 2024 |
| Deutsche Bank | David Begleiter | $65 | $57.03 | +458.9% | May 6, 2024 |
| RBC Capital | Arun Viswanathan | $64 | $57.16 | +450.3% | May 6, 2024 |
| Canaccord Genuity | Bobby Burleson | $65 | $56.98 | +458.9% | May 3, 2024 |
| BMO Capital | Joel Jackson | $67 | $56.98 | +476.1% | May 3, 2024 |
| Jefferies | Laurence Alexander | $67 | $57 | +476.1% | Mar 28, 2024 |
| Loop Capital Markets | Christopher Kapsch | $65 | $55.04 | +458.9% | Feb 12, 2024 |
| BNP Paribas | Laurent Favre | $53 | $53.04 | +355.7% | Feb 2, 2024 |
| Wells Fargo | Analyst unavailable | $77 | $61.54 | +562.1% | Feb 3, 2023 |
| Citigroup | Analyst unavailable | $74 | $61.68 | +536.3% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $80 | $62.12 | +587.9% | Jan 11, 2023 |
| Barclays | Analyst unavailable | $75 | $65.35 | +544.9% | Nov 17, 2022 |
| UBS | Analyst unavailable | $73 | $66.72 | +527.7% | Nov 16, 2022 |
| Credit Suisse | John Roberts | $68 | $51.26 | +484.7% | Jul 14, 2022 |
| Barclays | Benjamin Theurer | $71 | $53.22 | +510.5% | Jun 20, 2022 |
| Deutsche Bank | David Begleiter | $72 | $62.04 | +519.1% | Jun 6, 2022 |
| Argus Research | Bill Selesky | $69 | $60.91 | +493.3% | May 24, 2022 |
| Mizuho Securities | Analyst unavailable | $67 | $57.99 | +476.1% | Apr 29, 2022 |
| Roth Capital | Brian White | $56 | $50.25 | +381.5% | Feb 4, 2022 |
| Barclays | Duffy Fischer | $54 | $47.33 | +364.3% | Nov 5, 2021 |
| Deutsche Bank | David Begleiter | $55 | $44.79 | +372.9% | Aug 8, 2021 |
| Argus Research | Bill Selesky | $54 | $45.82 | +364.3% | May 17, 2021 |
| Bank of America Securities | Steve Byrne | $42 | $46.45 | +261.1% | May 10, 2021 |
Track every rating change on CTVA the moment it posts. Free to start.
Start freeGet the CTVA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.